← Open Payments lookup

MIRIAM MEDINA: Open Payments

NPI 1558037275 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,655 in 56 payments from 18 companies in 2025. Trend: 2023 $434 · 2024 $1,211 · 2025 $1,655

Food & beverage: $1,655
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation7$272
AstraZeneca Pharmaceuticals LP5$208
ARS Pharmaceuticals Operations, Inc.12$190
CSL Behring9$184
REVANCE THERAPEUTICS, INC.1$139
Takeda Pharmaceuticals U.S.A., Inc.5$130
Blueprint Medicines Corporation1$121
GlaxoSmithKline, LLC.5$107
ADMA BioManufacturing LLC1$91
Ionis Pharmaceuticals, Inc.2$45

Products named: Rhapsido, NEFFY, FASENRA, DAXI, AYVAKIT, Andembry, TRELEGY ELLIPTA, CUVITRU.

Industry payments across TX — which companies pay providers there.